Juan Pablo Roblero Selected Research

Juan Pablo Roblero Research Topics

2	Infections 01/2021 - 04/2019
2	Fibrosis (Cirrhosis) 04/2019 - 09/2002
1	End Stage Liver Disease 11/2021
1	Hepatitis 11/2021
1	Hepatitis A (Hepatitis, Infectious) 11/2021
1	Liver Diseases (Liver Disease) 11/2021
1	Neuroinflammatory Diseases 01/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Peritonitis 01/2021
1	Inflammation (Inflammations) 01/2021
1	Autism Spectrum Disorder 01/2021
1	Bacterial Infections (Bacterial Infection) 04/2019
1	Ascites 07/2009
1	Liver Cirrhosis (Hepatic Cirrhosis) 09/2002
1	Brain Diseases (Brain Disorder) 09/2002
1	Hepatic Encephalopathy 09/2002
1	Portal Hypertension 09/2002

2	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 04/2019
1	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2021
1	SteroidsIBA 11/2021
1	Malondialdehyde (Propanedial)IBA 01/2021
1	Ethanol (Ethyl Alcohol)IBA 01/2021
1	Analgesics (Analgesic Drugs)IBA 01/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	AldehydesIBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	AcetaldehydeIBA 01/2021
1	Morphine (MS Contin)FDA LinkGeneric 01/2021
1	BilirubinIBA 07/2009
1	Vasodilator Agents (Vasodilators)IBA 09/2002
1	Propranolol (Inderal)FDA LinkGeneric 09/2002
1	ReninIBA 09/2002
1	AldosteroneIBA 09/2002

1	Therapeutics 11/2021